Theoretical Arguments for the Discounting of Health Consequences Angelina Lazaro Current Opinion 21 September 2012 Pages: 943 - 961
Pharmacoeconomic Considerations in Assessing and Selecting Congestive Heart Failure Therapies Emile LevyPierre Levy Review Article 21 September 2012 Pages: 963 - 977
Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in the Secondary Prevention of Acute Coronary Syndrome Max BrosaCarlos Rubio-TerrésJenaro Froufe Original Research Article 21 September 2012 Pages: 979 - 987
Insulin Lispro Christopher J. DunnGreg L. Plosker Adis Pharmacoeconomic Drug Evaluation 21 September 2012 Pages: 989 - 1025